31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4297-4301

  Murata, Osamu ^a   Sakurai, Hideyuki ^a   Mitsuhashi, Norio ^a   Hasegawa, Masatoshi ^a   Yamakawa, Michitaka ^a   Kurosaki, Hiromasa ^a   Hayakawa, Kazushige ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

31P MRS; Fractionated irradiation; Growth fraction; Growth inhibition

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE; PHOSPHORUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CARCINOMA CELL; CONTROLLED STUDY; DEVICE; DOSE TIME EFFECT RELATION; MALE; METABOLITE; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIATION DOSE; SPECTROMETER; TUMOR GROWTH; ANIMAL; C3H MOUSE; CELL CULTURE; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; RADIATION DOSE FRACTIONATION; TIME;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE FRACTIONATION; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; PHOSPHATES; PHOSPHOCREATINE; PHOSPHORUS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032217235     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Niibe H, Tobe T, Koike N and Sakaino K: Tumor tissue structure and radio-sensitivity. II. Mammary cancer in C3H/He.Ms. strain mice. Nippon Acta Radiol 28: 1341-1349, 1969.
2. Ito I, Suzuki Y, Miyaishi K, Mitsuhachi N, Kimura M, Abe I and Niibe H: Treatment of local recurrence breast cancer by divided dose electron beam radiation twice a week. Nippon Acta Radiol 38: 221-229, 1978.
3. Izuo M: "Current Diagnosis and Treatment of Breast Cancer,"-pp. 322-334,1987. Nagai Shoten, Osaka. (in Japanese)
4. 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy. Int J Radiat Oncol Biol Phys 18: 1341-1350, 1990.
5. 31P NMR spectroscopy and microelectrodes. Radiat Res 727; 177-183, 1991.
6. 31P MRS. Magn Reson Imaging 12: 109-119, 1994.
7. Prescott DM, Charles HC, Sostman HD, Page RL, Thrall DE, Moore D, Oleson JR and Dewhirst MW: Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia. Int J Hyperthermia 9: 745-754, 1993.
8. Rodrigues LM, Midwood CJ, Coombes RC, Stevens AN, Stubbs M and Griffiths JR: P nuclear magnetic resonance spectroscopy studies of the response of rat mammary tumors to endocrine therapy. Cancer Res 48: 89-93, 1988.
9. Shine N, Palladino MA, Patton JS, Deisseroth A, Karczmar GS, Matson GB and Weiner MW: Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorous-31 magnetic resonance study. Cancer Res 49: 2123-2127, 1989.
10. 31P-nuclear magnetic resonanace spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. Br J Cancer 68: 1061-1070, 1993.
11. Tozer GM, Bhujwalla ZM, Griffiths JR and Maxwell RJ: Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int J Radiat Oncol Biol Phys 16: 155-164, 1989.
12. 2 tension measurements in a murine fibrosarcoma. Radiat Res 720: 477-493, 1989.
13. 31P-magnetic resonance spectroscopy. Radiother Oncol 24: 186-190, 1992.
14. 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia. Proc Natl Acad Sci 80: 334-338, 1983.
15. 31P MRS observations of tumor energy metabolism. NMR in Biomedicine 5: 279-289, 1992.